Abbas, F; Eladl, MA; El-Sherbiny, M; Abozied, N; Nabil, A; Mahmoud, SM; Mokhtar, HI; Zaitone, SA and Ibrahim, D (2022). Celastrol and thymoquinone alleviate aluminum chloride-induced neurotoxicity: Behavioral psychomotor performance, neurotransmitter level, oxidative-inflammatory markers, and BDNF expression in rat brain. Biomed. Pharmacother., 151: 113072.
Abenavoli, L; Izzo, AA; Milić, N; Cicala, C; Santini, A and Capasso, R (2018). Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytother. Res., 32: 2202-2213.
Ahmed, ZS O; Hussein, S; Ghandour, RA; Azouz, AA and El-Sakhawy, MA (2021). Evaluation of the effect of methotrexate on the hippocampus, cerebellum, liver, and kidneys of adult male albino rat: Histopathological, immunohistochemical and biochemical studies. Acta Histochem, 123: 151682.
Akhtar, MN; Saeed, R; Saeed, F; Asghar, A; Ghani, S; Ateeq, H; Ahmed, A; Rasheed, A; Afzaal, M and Waheed, M (2023). Silymarin: a review on paving the way towards promising pharmacological agent. Int. J. Food Prop., 26: 2256-2272.
Ashique, S; Mohanto, S; Kumar, N; Nag, S; Mishra, A; Biswas, A; Rihan, M; Srivastava, S; Bhowmick, M and Taghizadeh-Hesary, F (2024). Unlocking the possibilities of therapeutic potential of silymarin and silibinin against neurodegenerative Diseases-A mechanistic overview. Eur. J. Pharmacol., 981: 176906.
Aslani, MR; Saadat, S and Boskabady, MH (2024). Comprehensive and updated review on anti-oxidant effects of Nigella sativa and its constituent, thymoquinone, in various disorders. Iran. J. Basic Med. Sci., 27: 923-951.
Aslankoc, R; Savran, M; Doğuç, DK; Sevimli, M; Tekin, H and Kaynak, M (2022). Ameliorating effects of ramelteon on oxidative stress, inflammation, apoptosis, and autophagy markers in methotrexate-induced cerebral toxicity. Iran. J. Basic Med. Sci., 25: 1183.
Ayalon, I; Friedman, S; Binenbaum, Y; Oppenheimer, N; Shiran, S; Grisaru-Soen, G; Uliel-Sibony, S; Glatstein, M; Kaplan, JM and Sadot, E (2019). A case of methotrexate neurotoxicity presented as status epilepticus, encephalopathy, and high fever. J. Investig. Med. High Impact Case Rep., 7: 2324709619862311.
Bakhtiari, MK; Sharifiyazdi, H; Nazifi, S; Ghaemi, M and Zarandi, MH (2021). Effects of citral on serum antioxidant status and liver genes expressions of paraoxonase 1 and nitric oxide synthase in a rat model of streptozotocin-induced diabetes mellitus. Iran. J. Vet. Res., 22: 195.
Behairy, A; Elkomy, A; Elsayed, F; Gaballa, M M; Soliman, A and Aboubakr, M (2024). Antioxidant and anti-inflammatory potential of spirulina and thymoquinone mitigate the methotrexate-induced neurotoxicity. Naunyn Schmiedebergs Arch. Pharmacol., 397: 1875-1888.
Behdokht, B; Foad, NM; Saeed, N; Ahmadi, N and Sakineh, A (2024). Comparative study of the protective effects of citral, thymoquinone, and silymarin on methotrexate-induced cardiotoxicity in rats. J. Pharmacopuncture, 27: 245.
Cottin, V; Bendstrup, E; Bonniaud, P; Nasser, M; Spagnolo, P; Valenzuela, C and Kolb, M (2021). The case of methotrexate and the lung: Dr Jekyll and Mr Hyde.Eur. Respir. Soc. 57: 2100079.
Faraji, M; Noorbakhsh, MF; Kazemipour, N; Nazifi, S; Moradi, HR; Ahmadi, N and Azadmanesh, M (2025). Comparison of the effects of metformin, citral, Cymbopogon citratus extract and silver nanoparticles of Cymbopogon citratus extract on oxidative stress indices and Nrf2 levels in experimental type 2 diabetes in rats. Anim. Models Exp. Med. 8: 2128-2138.
Hamed, KM; Dighriri, IM; Baomar, AF; Alharthy, BT; Alenazi, FE; Alali, GH; Alenazy, RH; Alhumaidi, NT; Alhulayfi, DH and Alotaibi, YB (2022). Overview of methotrexate toxicity: a comprehensive literature review. Cureus, 14. e29518.
Idrees, M; Hakkim, FL; Naikoo, GA and Ul Hassan, I (2019). Recent advances in extraction, characterization, and potential use of citral. Biotechnol. Bioeng. Mol. Approaches, 3: 225-236.
Jomova, K; Alomar, SY; Alwasel, SH; Nepovimova, E; Kuca, K and Valko, M (2024). Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants. Arch. Toxicol., 98: 1323-1367.
Kandemir, FM; Kucukler, S; Caglayan, C; Gur, C; Batil, AA and Gülçin, İ (2017). Therapeutic effects of silymarin and naringin on methotrexate‐induced nephrotoxicity in rats: Biochemical evaluation of anti‐inflammatory, antiapoptotic, and antiautophagic properties. J. Food Biochem., 41: e12398.
Khatinasab, S; Kazemipour, N; Noorbakhsh, MF; Nazifi, S; Faraji, M and Ahmadi, N (2025). Evaluation of citral and green silver nanoparticles from Cymbopogon citratus extract on biochemical profile and nrf2 gene expression in liver tissue of type 2 diabetic rats. Biomed Res. Int., 2025: 9266092.
Kougkas, N; Dara, A; Pagkopoulou, E; Dimitriadou, A; Papadimitriou, E; Avdelidou, E; Garyfallos, A and Dimitroulas, T (2022). Methotrexate induced neurotoxicity in a patient with rheumatoid arthritis on rituximab therapy: a case-based review. Rheumatol. Int., 42: 1849-1854.
Li, CC; Yu, HF; Chang, CH; Liu, YT and Yao, HT (2018). Effects of lemongrass oil and citral on hepatic drug-metabolizing enzymes, oxidative stress, and acetaminophen toxicity in rats. J. Food Drug Anal., 26: 432-438.
Mohamed, AE; El-Magd, MA; El-Said, KS; El-Sharnouby, M; Tousson, EM and Salama, AF (2021). Potential therapeutic effect of thymoquinone and/or bee pollen on fluvastatin-induced hepatitis in rats. Sci. Rep., 11: 15688.
Nakamura, Y; Miyamoto, M; Murakami, A; Ohigashi, H; Osawa, T and Uchida, K (2003). A phase II detoxification enzyme inducer from lemongrass: identification of citral and involvement of electrophilic reaction in the enzyme induction. Biochem. Biophys. Res. Commun., 302: 593-600.
Perez, JL; Jayaprakasha, GK; Cadena, A; Martinez, E; Ahmad, H and Patil, BS (2010). In vivo induction of phase II detoxifying enzymes, glutathione transferase and quinone reductase by citrus triterpenoids. BMC Complement. Altern. Med., 10: 1-8.
Sakineh, A; Noorbakhsh, MF; Ahmadi, N; Saeed, N and Behdokht, B (2023). Evaluation of the protective effect of citral, silymarin, and thymoquinone on methotrexate-induced lung injury in rats. J. Pharmacopuncture, 26: 184.
Sayyad, M; Sutar, AD; Shivhare, K; Shukla, R and Flora, SJS (2025). Silymarin as a phytopharmaceutical agent: advances in mechanistic insights, formulation strategies, and pre-clinical applications. Eur. Respir. Soc., 16: 1711653.
Su, YW; Chen, KM; Hassanshahi, M; Tang, Q; Howe, PR and Xian, CJ (2017). Childhood cancer chemotherapy–induced bone damage: pathobiology and protective effects of resveratrol and other nutraceuticals. Ann. N. Y. Acad. Sci., 1403: 109-117.
Vezmar, S; Becker, A; Bode, U and Jaehde, U (2003). Biochemical and clinical aspects of methotrexate neurotoxicity. Chemother., 49: 92-104.
Watanabe, K; Arakawa, Y; Oguma, E; Uehara, T; Yanagi, M; Oyama, C; Ikeda, Y; Sasaki, K;Isobe, K and Mori, M (2018). Characteristics of methotrexate-induced stroke-like neurotoxicity. Int. J. Hematol., 108: 630-636.
Xu, M; Wu, S; Wang, Y; Zhao, Y; Wang, X; Wei, C; Liu, X; Hao, F and Hu, C (2022). Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia. Eur. Respir. Soc., 13: 1003812.
Yardım, A; Kucukler, S; Özdemir, S; Çomaklı, S; Caglayan, C; Kandemir, FM and Çelik, H (2021). Silymarin alleviates docetaxel-induced central and peripheral neurotoxicity by reducing oxidative stress, inflammation and apoptosis in rats. Gene, 769: 145239.